Medical Big Data

Precision Oncology Leader to Participate at Investment Conference

Genetron Holdings Limited

Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced that management will host virtual investor meetings at the 24th Credit Suisse Asian Investment Conference on Mar. 26th, 2021.

Sizhen Wang, co-founder and Chief Executive Officer, will also attend a fireside chat at 3:00 pm Beijing time (3:00 am ET).

Interested parties may request more information by contacting their sales representative at Credit Suisse.

Business Wire

Business Wire is a trusted source for news organizations, journalists, investment professionals and regulatory authorities, delivering news directly into editorial systems and leading online news sources via its multi-patented NX Network. Business Wire has 18 newsrooms worldwide to meet the needs of communications professionals and news media.

Related posts

Pulse Infoframe & Quinten Health Partner For Precision Medicine

PR Newswire

ASCO 2024 study uses ConcertAI Oncology Dataset to find earlier treatment

PR Newswire

Biognosys Announces Strategic Agreement with Siemens Healthineers

Business Wire